SYMPATHOLYTIC DRUGS AND HYPERLIPAEMIA INDUCED IN RATS BY INTRAPERITONEAL INJECTIONS OF SURFACE-ACTIVE AGENT.
D001949:Bretylium Compounds; D004983:Ethanolamines; D005227:Fatty Acids; D006145:Guanethidine; D006937:Hypercholesterolemia; D006949:Hyperlipidemias; D007274:Injections, Intraperitoneal; D007545:Isoproterenol / Q000031:analogs & derivatives; D010600:Pharmacology; D010643:Phenoxybenzamine; D010646:Phentolamine; D051381:Rats; D012106:Research; D013501:Surface-Active Agents; D013565:Sympatholytics; D014116:Toxicology
D001949:Bretylium Compounds; D004983:Ethanolamines; D005227:Fatty Acids; D013501:Surface-Active Agents; D013565:Sympatholytics; D010643:Phenoxybenzamine; D007545:Isoproterenol; C084581:dichloroisoproterenol; C084832:pronethalol; D010646:Phentolamine; D006145:Guanethidine
BRETYLIUM COMPOUNDS; DICHLOROISOPROTERENOL; EXPERIMENTAL LAB STUDY; FATTY ACIDS; GUANETHIDINE; HYPERCHOLESTEREMIA; HYPERLIPEMIA; INJECTIONS, INTRAPERITONEAL; PHARMACOLOGY; PHENOXYBENZAMINE; PHENTOLAMINE; PRONETHALOL; RATS; SURFACE-ACTIVE AGENTS; SYMPATHOLYTICS; TOXICOLOGIC REPORT